10-Q: P&G Q2 Earnings: Sales Up 1%, Restructuring Weighs on Profit

Procter & Gamble reports a 1% net sales increase to $22.2 billion for Q2 FY26, with diluted EPS down 5% due to significant restructuring charges.

Summary

• Net sales for the three months ended December 31, 2025, increased 1% to $22.208 billion, driven by favorable foreign exchange (1%) and higher pricing (1%), partially offset by a 1% decline in unit volume.
• Organic sales for the three months ended December 31, 2025, were unchanged.
• Net sales for the six months ended December 31, 2025, increased 2% to $44.594 billion, with organic sales up 1%.
• Net earnings attributable to Procter & Gamble decreased 7% to $4.319 billion for the three months ended December 31, 2025, but increased 6% to $9.070 billion for the six months ended December 31, 2025.
• Diluted net earnings per common share decreased 5% to $1.78 for the three months ended December 31, 2025, but increased 7% to $3.73 for the six months ended December 31, 2025.
• Operating income decreased 7% to $5.366 billion for the three months and 3% to $11.222 billion for the six months.
• Gross margin declined by 120 basis points to 51.2% for the three months and 90 basis points to 51.3% for the six months, primarily due to unfavorable product mix, higher restructuring costs, product/packaging investments, and tariffs.
• Selling, general and administrative (SG&A) expense as a percentage of net sales increased 90 basis points to 27.1% for the three months, mainly due to increased marketing spending and overhead costs.
• Operating cash flow for the six months ended December 31, 2025, was $10.380 billion, an increase of $1.3 billion from the prior year period.
• Adjusted free cash flow for the six months was $8.701 billion, with an adjusted free cash flow productivity of 95%.
• The company is executing a portfolio and productivity plan, expecting $1.5 to $2.0 billion in before-tax restructuring costs over two years, including a reduction of up to 7,000 non-manufacturing overhead personnel by the end of fiscal 2027.
• For the six months ended December 31, 2025, $584 million in before-tax restructuring charges were incurred under this plan.
• The company expects to receive approximately $500 million in cash proceeds and record an after-tax gain of $250 to $300 million in Q3 FY26 from the sale of its minority interest in the Glad joint venture to The Clorox Company.

Sentiment

Score: 6

Explanation: The company shows modest sales growth and strong cash flow generation, but profitability is impacted by significant restructuring charges and gross margin pressures. The strategic adjustments and planned divestiture are positive long-term moves, but short-term earnings are soft, and market share declines in several categories warrant caution.

Positives

• Net sales increased 1% for the three months and 2% for the six months ended December 31, 2025, demonstrating overall revenue growth.
• Organic sales increased 1% for the six months ended December 31, 2025, indicating underlying business growth excluding foreign exchange and acquisitions/divestitures.
• Diluted EPS increased 7% for the six months ended December 31, 2025, reflecting improved earnings over the longer interim period.
• Core EPS, which excludes incremental restructuring charges, increased 2% for the six months, highlighting stronger underlying operational performance.
• Operating cash flow increased by $1.3 billion to $10.380 billion for the six months, indicating robust cash generation.
• Adjusted free cash flow productivity was strong at 95% for the six months, demonstrating efficient cash conversion from earnings.
• Beauty segment net sales increased 5% for the three months and 6% for the six months, with organic sales up 4% and 5% respectively, showing strong performance.
• Health Care segment net sales increased 5% for the three months and 4% for the six months, with organic sales up 3% and 2% respectively, and global market share increased by 0.3 points.
• Productivity savings contributed 170 basis points to gross margin and 100 basis points to SG&A as a percentage of net sales for the six months.
• The planned sale of the Glad joint venture minority interest is expected to generate approximately $500 million in cash and an after-tax gain of $250 to $300 million.
• The company has strong shortand long-term debt ratings, enabling favorable refinancing and access to capital markets.

Negatives

• Diluted net earnings per common share decreased 5% for the three months ended December 31, 2025, compared to the prior year.
• Net earnings attributable to Procter & Gamble decreased 7% for the three months ended December 31, 2025.
• Operating income decreased 7% for the three months and 3% for the six months ended December 31, 2025.
• Gross margin declined by 120 basis points for the three months and 90 basis points for the six months, primarily due to unfavorable product mix, higher restructuring costs, product and packaging investments, and higher tariffs.
• SG&A as a percentage of net sales increased 90 basis points for the three months, driven by increased marketing spending and overhead costs.
• Baby, Feminine & Family Care net sales decreased 3% for the three months and 1% for the six months, with organic sales declining 4% and 2% respectively.
• Global market share decreased in Beauty (0.3-0.4 points), Grooming (0.4-0.6 points), Fabric & Home Care (0.2-0.3 points), and Baby, Feminine & Family Care (0.3-0.2 points) segments for the respective periods.
• Family Care net sales decreased double digits for the three months and mid-single digits for the six months, with North America market share decreasing 1.1 points and 0.9 points respectively.
• Current liabilities exceeded current assets by $10.1 billion as of December 31, 2025.

Risks

• Ability to successfully manage global financial risks, including foreign currency fluctuations, changes in global interest rates and rate differentials, currency exchange, or pricing controls and tariffs.
• Ability to successfully manage local, regional or global economic volatility, including reduced market growth rates, and to generate sufficient income and cash flow.
• Uncertainties related to changing political and geopolitical conditions and potential implications such as exchange rate fluctuations, market contraction, boycotts, variability and unpredictability in trade relations, sanctions, tariffs or other trade controls.
• Ability to manage disruptions in credit markets or to banking partners or changes to credit rating.
• Ability to maintain key manufacturing and supply arrangements and to manage disruption of business due to various factors, including natural disasters, acts of war or terrorism or disease outbreaks.
• Ability to successfully manage cost fluctuations and pressures, including prices of commodities and raw materials and costs of labor, transportation, energy, pensions and healthcare.
• Ability to compete with local and global competitors in new and existing sales channels, including by successfully responding to competitive factors such as prices, promotional incentives and trade terms for products.
• Ability to manage and maintain key customer relationships.
• Ability to protect reputation and brand equity by successfully managing real or perceived issues, including concerns about safety, quality, ingredients, efficacy, packaging content, supply chain practices, social or environmental practices.
• Ability to successfully manage the financial, legal, reputational and operational risk associated with third-party relationships, such as suppliers, contract manufacturers, distributors, contractors and external business partners.
• Ability to rely on and maintain key company and third-party information and operational technology systems, networks and services and maintain the security and functionality of such systems and data.
• Ability to successfully manage the demand, supply and operational challenges, as well as governmental responses or mandates, associated with a disease outbreak.
• Ability to stay on the leading edge of innovation, obtain necessary intellectual property protections and successfully respond to changing consumer habits, evolving digital marketing and selling platform requirements and technological advances.
• Ability to successfully manage ongoing acquisition, divestiture and joint venture activities.
• Ability to successfully achieve productivity improvements and cost savings and manage ongoing organizational changes while successfully identifying, developing and retaining key employees.
• Ability to successfully manage current and expanding regulatory and legal requirements and matters (including product liability, product and packaging composition, manufacturing processes, intellectual property, labor and employment, antitrust, privacy, cybersecurity, data protection, artificial intelligence, tax, environment, due diligence, risk oversight, accounting and financial reporting).
• Ability to manage changes in applicable tax laws and regulations.
• Ability to continue delivering progress towards environmental sustainability ambitions.
• Adverse changes in the business or macroeconomic environment, including foreign currency devaluation, increasing global inflation, or market contraction from an economic recession, could reduce the underlying cash flows used to estimate the fair value of the Gillette indefinite-lived intangible asset and trigger an impairment charge.
• A 25 basis-point increase in the discount rate, a 25 basis-point decrease in short-term and residual growth rates, or a 50 basis-point decrease in the royalty rate could reduce the estimated fair value of the Gillette indefinite-lived intangible asset by 4-5%.
• Litigation and environmental contingencies, though currently not expected to materially affect financial position, results of operations or cash flows.
• Uncertain tax positions in multiple jurisdictions, with approximately $124 million in accrued liabilities (including interest and penalties) anticipated to be completed over the next 12 months.

Future Outlook

The company expects to incur $1.5 to $2.0 billion in before-tax restructuring costs over a two-year period, with half by the end of fiscal 2026 and the remainder in fiscal 2027. This plan includes a reduction of up to 7,000 non-manufacturing overhead personnel by the end of fiscal 2027. The sale of its minority interest in the Glad joint venture is anticipated to generate approximately $500 million in cash proceeds and an after-tax gain of $250 to $300 million in the third quarter of the fiscal year ended June 30, 2026. The company also expects to reduce outstanding shares through direct share repurchases of approximately $5 billion in fiscal year 2026.

Management Comments

• This report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
• The financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.
• Our disclosure controls and procedures were effective to ensure that information required to be disclosed in reports we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and (2) accumulated and communicated to our management... to allow their timely decisions regarding required disclosure.
• There were no changes in our internal control over financial reporting that occurred during the Company's fiscal quarter ended December 31, 2025, that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

Industry Context

Procter & Gamble operates in a highly competitive global fast-moving consumer goods industry, facing competition from both branded products and private-label brands across various price tiers. The company's performance is significantly influenced by global macroeconomic factors, geopolitical tensions, and government policies, particularly given that over half of its sales are generated outside the United States. P&G is actively managing cost pressures from commodity prices, inflation, and supply chain disruptions through productivity initiatives and strategic optimizations, while also navigating evolving consumer habits and digital marketing landscapes.

Comparison to Industry Standards

• The filing states that the company competes against other branded products as well as retailers' private-label brands in many markets and industry segments.
• The company believes it is well positioned in the industry segments and markets in which it operates, often holding a leadership or significant market share position.
• No specific comparable companies, projects, or results from competitors are detailed in the filing for direct comparison to industry standards.

Corporate Governance

Legal Proceedings

• The company is subject to various legal proceedings and claims, including antitrust, product liability, advertising, contracts, environmental, patent and trademark, labor and employment, and tax matters. Management believes the ultimate resolution will not materially affect financial position, results of operations, or cash flows.
• Subject to contingencies pursuant to environmental laws and regulations, but the ultimate resolution of environmental remediation is not believed to materially affect financial position, results of operations, or cash flows.
• The company has 30-40 jurisdictional tax audits underway. It anticipates audit activity could be completed related to uncertain tax positions in multiple jurisdictions over the next 12 months, for which approximately $124 million (including interest and penalties) has been accrued.

Stakeholder Impact

• Shareholders: Impacted by decreased diluted EPS in Q2 but increased H1 EPS. Share repurchase program and expected gain from Glad JV sale are positive. Dividends to shareholders used $5.093 billion cash in H1.
• Employees: Up to 7,000 non-manufacturing overhead personnel reduction planned by the end of fiscal 2027 due to restructuring.
• Suppliers: The Supply Chain Finance program allows participating suppliers to sell receivables to SCF banks, potentially providing more favorable terms.
• Customers: Product pricing increases may negatively impact product consumption. Innovation and product investments aim to maintain customer appeal and market share.

Next Steps

• Incur the remaining half of the $1.5 to $2.0 billion in before-tax restructuring costs in fiscal 2027.
• Complete the reduction of up to 7,000 non-manufacturing overhead personnel by the end of fiscal 2027.
• The Clorox Company will purchase P&G's minority interest in the Glad joint venture in January 2026.
• Expect to receive approximately $500 million in cash proceeds and record an after-tax gain of $250 to $300 million from the Glad JV sale in Q3 FY26.
• Reduce outstanding shares through direct share repurchases of approximately $5 billion in fiscal year 2026.
• Implement new accounting pronouncements: ASU 2023-09 (Income Taxes) effective for fiscal year ending June 30, 2026; ASU 2024-03 (Expense Disaggregation) effective for fiscal year ending June 30, 2028; ASU 2025-06 (Internal-Use Software) effective for fiscal year ending June 30, 2029; and ASU 2025-10 (Government Grants) effective for fiscal year ending June 30, 2030.

Key Dates

Recommendation

While P&G demonstrates resilience with modest sales growth and strong cash flow generation, the short-term earnings decline and gross margin compression due to significant restructuring costs, unfavorable mix, and tariffs are concerning. The strategic restructuring and Glad JV divestiture are positive long-term moves, but the immediate impact on profitability and market share losses in several key categories suggest a 'hold' position until the benefits of these initiatives become clearer and market share trends stabilize. The company's strong brand portfolio and cash flow provide stability, but the current headwinds warrant caution.

Keywords

Procter & Gamble, P&G, Quarterly Report, 10-Q, Earnings, Net Sales, EPS, Organic Sales, Restructuring, Consumer Goods, FMCG, Financial Results, Share Repurchase, Dividends, Supply Chain, Tariffs, Foreign Exchange, Market Share, Gillette, Beauty, Grooming, Health Care, Fabric & Home Care, Baby Feminine & Family Care